Kiwi Wealth Investments Limited Partnership’s United Therapeutics UTHR Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,626	Closed	-$3.45M	–	262
2022 Q3	$3.45M	Hold	14,626	–	–	0.24%	113
2022 Q2	$3.45M	Buy	+14,626	New	+$2.97M	0.24%	113
2021 Q1	–	Sell	-1,942	Closed	-$295K	–	283
2020 Q4	$295K	Sell	1,942 -17,027	-90%	-$2.23M	0.02%	247
2020 Q3	$1.92M	Hold	18,969	–	–	0.13%	180
2020 Q2	$2.29M	Buy	+18,969	New	+$2.13M	0.19%	131

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's UTHR Position: Q4 2022 in Review

Kiwi Wealth Investments Limited Partnership sold out of United Therapeutics (UTHR) in Q4 2022, closing a stake of 14,626 shares — an estimated $3.45M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in UTHR in Q2 2020 and held it in 5 quarters. The position peaked at $3.45M in Q3 2022. 511 funds tracked by Wall St. Rank hold UTHR as of Q4 2022.

Kiwi Wealth Investments Limited Partnership reported no remaining United Therapeutics position as of Q4 2022 after selling out during the quarter.
Kiwi Wealth Investments Limited Partnership sold 14,626 United Therapeutics shares in Q4 2022, an estimated $3.45M.
Kiwi Wealth Investments Limited Partnership first reported a position in United Therapeutics in Q2 2020 and held it in 5 quarters.
Kiwi Wealth Investments Limited Partnership's United Therapeutics position peaked at $3.45M in Q3 2022.
511 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2022.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q4 2022, filed 15 Feb 2023.